Cargando…

Modeling tumor measurement data to predict overall survival (OS) in cancer clinical trials

INTRODUCTION: Longitudinal tumor measurements (TM) are commonly recorded in cancer clinical trials of solid tumors. To define patient response to treatment, the Response Evaluation Criteria in Solid Tumors (RECIST) categorizes the otherwise continuous measurements, which results in substantial infor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ou, Fang-Shu, Tang, Jun, An, Ming-Wen, Mandrekar, Sumithra J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365311/ https://www.ncbi.nlm.nih.gov/pubmed/34430754 http://dx.doi.org/10.1016/j.conctc.2021.100827

Ejemplares similares

Missing tumor measurement (TM) data in the search for alternative TM-based endpoints in cancer clinical trials
por: An, Ming-Wen, et al.
Publicado: (2019)

Genomic advances and their impact on clinical trial design
por: Mandrekar, Sumithra J, et al.
Publicado: (2009)

phase1RMD: An R package for repeated measures dose-finding designs with novel toxicity and efficacy endpoints
por: Yin, Jun, et al.
Publicado: (2021)

The Direct Assignment Option as a Modular Design Component: An Example for the Setting of Two Predefined Subgroups
por: An, Ming-Wen, et al.
Publicado: (2015)

Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer
por: Xie, Qiqi, et al.
Publicado: (2020)

Metabolic tumor volume predicts overall survival in patients with primary pulmonary lymphoepithelioma-like carcinoma
por: Lin, Chun-Yu, et al.
Publicado: (2019)

Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials
por: Le-Rademacher, Jennifer G., et al.
Publicado: (2020)

Prediction of overall survival in patients across solid tumors following atezolizumab treatments: A tumor growth inhibition–overall survival modeling framework
por: Chan, Phyllis, et al.
Publicado: (2021)

Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC)
por: Zhengqi, Qiu, et al.
Publicado: (2021)

Development and Validation of a Nomogram for Predicting Overall Survival in Pancreatic NeuroendocrineTumors()()
por: Miao, Dong-liu, et al.
Publicado: (2018)

Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical Trials
por: Le-Rademacher, Jennifer G., et al.
Publicado: (2019)

Prognostic Factors and Nomograms to Predict Overall and Cancer-Specific Survival for Children with Wilms' Tumor
por: Tang, Fucai, et al.
Publicado: (2019)

A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma
por: Zhang, Shu-Wen, et al.
Publicado: (2022)

The application of clinical variable-based nomogram in predicting overall survival in malignant phyllodes tumors of the breast
por: Li, Wei, et al.
Publicado: (2023)

The impact of insurance status on progression-free survival (PFS) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)
por: Castro, Daniela, et al.
Publicado: (2023)

Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer
por: Su, Yung-Yeh, et al.
Publicado: (2023)

Development and Validation of an Individualized Nomogram for Predicting Overall Survival in Patients With Typical Lung Carcinoid Tumors
por: Dong, Shenghua, et al.
Publicado: (2020)

Nomogram to predict overall survival and disease-specific survival with appendiceal mucinous adenocarcinoma
por: Yan, Qian, et al.
Publicado: (2019)

Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients
por: Tang, Huamei, et al.
Publicado: (2020)

Development and validation of nomogram with tumor microenvironment-related genes and clinical factors for predicting overall survival of endometrial cancer
por: Chen, Qian, et al.
Publicado: (2021)

Develop a nomogram to predict overall survival of patients with borderline ovarian tumors
por: Gong, Xiao-Qin, et al.
Publicado: (2022)

New nomograms to predict overall and cancer‐specific survival of angiosarcoma
por: Liu, Yuan‐Yuan, et al.
Publicado: (2021)

Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials
por: Nie, Run-Cong, et al.
Publicado: (2020)

Predictive Model for Overall Survival and Cancer-Specific Survival in Patients with Esophageal Adenocarcinoma
por: Huang, He, et al.
Publicado: (2021)

A Preoperative Nutritional Index for Predicting Cancer-Specific and Overall Survival in Chinese Patients With Laryngeal Cancer: A Retrospective Study
por: Fu, Yan, et al.
Publicado: (2016)

Prediction of overall survival in resectable intrahepatic cholangiocarcinoma: IS(ICC)‐applied prediction model
por: Tian, Mengxin, et al.
Publicado: (2020)

The impact of previous cancer on overall survival of bladder cancer patients and the establishment of nomogram for overall survival prediction
por: Wang, Zhengquan, et al.
Publicado: (2020)

Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data
por: Haricharan, Svasti, et al.
Publicado: (2014)

The radiosensitivity index predicts for overall survival in glioblastoma
por: Ahmed, Kamran A., et al.
Publicado: (2015)

Helios Expression in Tumor-Infiltrating Lymphocytes Correlates with Overall Survival of Advanced Gastric Cancer Patients
por: Chen, Wei-Ming, et al.
Publicado: (2020)

Identification of Pathway-Based Biomarkers with Crosstalk Analysis for Overall Survival Risk Prediction in Breast Cancer
por: Liu, Xiaohua, et al.
Publicado: (2021)

Machine Learning–Based Overall Survival Prediction of Elderly Patients With Multiple Myeloma From Multicentre Real-Life Data
por: Bao, Li, et al.
Publicado: (2022)

Nomogram application to predict overall and cancer-specific survival in osteosarcoma
por: Zheng, Weipeng, et al.
Publicado: (2018)

Effect of machine learning methods on predicting NSCLC overall survival time based on Radiomics analysis
por: Sun, Wenzheng, et al.
Publicado: (2018)

Surrogate Endpoints for Overall Survival in Immune-Oncology Trials of Advanced Gastro-Esophageal Carcinoma
por: Li, Yuan Fang, et al.
Publicado: (2022)

Nomograms Predict Overall Survival and Cancer-Speciﬁc Survival in Patients with Fibrosarcoma: A SEER-Based Study
por: Xiang, Guang-Heng, et al.
Publicado: (2020)

Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non–Small Cell Lung Cancer Trials Using Real-World Data
por: Ton, Thanh G.N., et al.
Publicado: (2022)

Bayesian forecasting of tumor size metrics and overall survival
por: Krishnan, Sreenath M., et al.
Publicado: (2022)

Overall Survival Prediction for Gliomas Using a Novel Compound Approach
por: Huang, He, et al.
Publicado: (2021)

Discovery of Prognostic Signature Genes for Overall Survival Prediction in Gastric Cancer
por: Meng, Changyuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mfolcka4b56kd6noan8b9s219g